Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Biotech

Cardiologist checking a patient's heart.

Who Are Cardiologists, And What Do They Do?

The term “Cardiology” comes from the Greek words for the heart (kardia) and to study (-logia). Thus, cardiologists are physicians who study the anatomy and physiology of the heart, its associated structures, their pathologies, and the prevention and treatment of disorders affecting the heart. Diseases treated by cardiologists Disorders commonly treated by cardiologists include: How does …

Who Are Cardiologists, And What Do They Do? Read More »

Signs a Site is Not the Right Fit for Your Clinical Trial

5 Signs a Site is Not the Right Fit for Your Clinical Trial

Nearly 80% of all clinical trials will experience significant delays, with as much as 50% of research sites failing to enroll more than one patient. The success of clinical trials primarily hinges on the individual sites chosen by the sponsor. Site selection is easily one of the most critical stages of the clinical trial development process. In …

5 Signs a Site is Not the Right Fit for Your Clinical Trial Read More »

Biotechs struggles with clinical trial starup.

5 Challenges of Clinical Trial Startup and How to Solve Them

Nearly three-quarters of all clinical trials will run one month behind during their startup phase, and in that time, sponsors can lose anywhere from US$600,000 to US$8M in revenue for every day of the delay. Stakeholders are well-aware that the more prompt the startup, the fewer timeline delays and unexpected expenses occur. Although these projects …

5 Challenges of Clinical Trial Startup and How to Solve Them Read More »

How technology is helping the clinical trial landscape

How Technology Is Helping the Clinical Trial Space

During 2022, ClinicalTrials.gov registered an additional 30,752 clinical trials, bringing the total record up to 430,269. Testing new drugs and treatments is a critical part of supporting public health. Clinical research ensures that patients can get the therapies they need to manage acute illnesses and chronic conditions. However, the clinical trial process is often cumbersome. …

How Technology Is Helping the Clinical Trial Space Read More »

What is Fixed-Fee Pricing, and How Does It Benefit Sponsors?

The way contract research organizations (CROs) are handling pricing is in desperate need of an overhaul. Many CROs win trials based on attractive upfront pricing, but the actual cost to sponsors over the lifetime of a trial may be significantly understated; the practice of using change orders to increase cost over time is a source …

What is Fixed-Fee Pricing, and How Does It Benefit Sponsors? Read More »

A decision maker at a small biotech company contemplates what CRO to choose for their clinical trial.

What Small Biotech Sponsors Should Look For When Choosing a CRO

With the increasing availability of advanced technology, more and more pharmaceutical companies are turning to contract research organizations (CROs) to maximize their clinical development outcomes. The market for CROs was estimated to account for nearly 53.9 billion USD in 2021. By 2028, this value is expected to grow by nearly 7%. This significant shift towards …

What Small Biotech Sponsors Should Look For When Choosing a CRO Read More »